May 2 (Reuters) - AstraZeneca PLC :
* AMOLYT PHARMA GRANTED FDA FAST TRACK DESIGNATION FOR ENEBOPARATIDE FOR TREATMENT OF HYPOPARATHYROIDISM
Source text for Eikon: Further company coverage:
((reuters.briefs@thomsonreuters.com;))
May 2 (Reuters) - AstraZeneca PLC :
* AMOLYT PHARMA GRANTED FDA FAST TRACK DESIGNATION FOR ENEBOPARATIDE FOR TREATMENT OF HYPOPARATHYROIDISM
Source text for Eikon: Further company coverage:
((reuters.briefs@thomsonreuters.com;))
Comments